Nachrichten zur Maravai LifeSciences Holdings Aktie

Maravai LifeSciences projects FY revenue near mid-range guidance; shares fall By Investing.com

Maravai LifeSciences projects FY revenue near mid-range guidance; shares fall…

Maravai LifeSciences: Still Struggling To Find Its Footing

…

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript

…

Maravai LifeSciences plant die Übernahme des DNA- und RNA-Geschäfts von Officinae Bio und fördert damit die Unterstützung innovativer Nukleinsäureforschung

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), ein globaler Anbieter von Reagenzien und Dienstleistungen im Bereich der Biowissenschaften für Forscher…

Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript

MRVI earnings call for the period ending September 30, 2024.…

Maravai LifeSciences Cygnus & TriLink Unveil AccuRes DNA Kits

MRVIs Cygnus and TriLink introduce AccuRes kits, setting a new standard in host cell DNA quantification with unmatched sensitivity and…

Maravai Lifesciences Shares Soar After Reported Takeover Offer

Maravai Lifesciences Holdings Inc. shares soared after a report that the company received a takeover offer from Repligen Corp.…

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life…

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2024 Earnings Call Transcript

…

Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2024.…

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024

SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of…

Maravai LifeSciences executives execute $97.57 million stock sale By Investing.com

Maravai LifeSciences executives execute $97.57 million stock sale…

Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript

MRVI earnings call for the period ending March 31, 2024.…

Maravai LifeSciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation

…

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript

…

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life…

Earnings call: Maravai LifeSciences outlines robust 2023 performance By Investing.com

Earnings call: Maravai LifeSciences outlines robust 2023 performance…

Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2023 Earnings Call Transcript

…

Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript

MRVI earnings call for the period ending December 31, 2023.…

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”)…

Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024

SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of…

Maravai LifeSciences: Still Trying To Right The Ship

…

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript

…

Maravai LifeSciences Holdings, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript

MRVI earnings call for the period ending September 30, 2023.…

Maravai LifeSciences: Falling Victim To COVID Boom And Bust

…

Maravai LifeSciences Hosts 2023 Investor R&D Day

Highlights include the company’s strong foundation for growth, focus on innovation and attractive long-term outlook Highlights include the company’s strong…

Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100

SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life…

Maravai LifeSciences falls as Q2 miss prompts KeyBanc downgrade

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Maravai LifeSciences (MRVI) Q2 2023 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2023....…

Maravai down 11% on Q2 misses, 2023 guidance cuts

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Maravai LifeSciences Shares Tumble 11% on Lowered 2023 Rev Outlook

Maravai LifeSciences Shares Tumble 11% on Lowered 2023 Rev Outlook...…

Maravai LifeSciences Holdings Non-GAAP EPS of $0.00 misses by $0.01, revenue of $68.9M misses by $2.23M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K MARAVAI LIFESCIENCES For: Aug 07

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Maravai LifeSciences appoints CEO

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition

William “Trey” Martin, III assumes the role of Maravais CEO...…

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023

SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider…

Form 8-K MARAVAI LIFESCIENCES For: Jul 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Maravai gains amid report of $17 a share takeover bid from Thomas H. Lee

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

TriLink BioTechnologies® kündigt im Zuge der bevorstehenden Fertigstellung der mRNA-Produktionsanlage Ausweitung der Fertigungsfähigkeiten an

SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), ein Maravai LifeSciences-Unternehmen (NASDAQ: MRVI) und globaler Lieferant von biowissenschaftlichen Reagenzien und Dienstleistungen, hat die…

dpa-AFX ProFeed